Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
4
Filing Date
8/20/2026
Updated
8/21/26, 2:06 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership